Piastrinopenia indotta da eparina: patogenesi, manifestazioni cliniche e management in emodialisi
Pasquale Esposito(Ospedale Policlinico San Martino), Antonio Dal Canton(University of Pavia), Marta Calatroni, Francesca Montagna, Elisa Margiotta(University of Pavia), Salvatore Romeo, Edoardo La Porta(University of Genoa), Marisa Barone, Michele Canevari(University of Pavia), Ilaria Borettaz(University of Pavia), Carmelo Libetta(University of Pavia), Claudia Martinelli(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Giornale Italiano di Nefrologia
May 1, 2014
Cited by 0
Related Papers
Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors
|International Journal of Molecular Sciences|2020|194
Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy
|Journal of Nephrology|2020|82
Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis
|Frontiers in Oncology|2024|74
Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
|Cancer Treatment Reviews|2023|61
GRAVITY AND TOPOGRAPHY
|Mars|2018|40